___

• Aydin, S. (2014). Three new players in energy regulation: preptin, adropin and irisin. Peptides, 56, 94-110. doi:10.1016/j.peptides.2014.03.021
• Bostrom, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., . Spiegelman, B. M. (2012). A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481(7382), 463-468. doi:10.1038/nature10777
• Butler, A. A., Tam, C. S., Stanhope, K. L., Wolfe, B. M., Ali, M. R., O'Keeffe, M., Havel, P. J. (2012). Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab, 97(10), 3783-3791. doi:10.1210/jc.2012-2194
• Cheng, K. C., Li, Y. X., Asakawa, A., Ushikai, M., Kato, I., Sato, Y., . . . Inui, A. (2012). Characterization of preptin-induced insulin secretion in pancreatic beta-cells. J Endocrinol, 215(1), 43-49. doi:10.1530/JOE-12-0176
• El-Eshmawy, M., & Abdel Aal, I. (2015). Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults. Appl Physiol Nutr Metab, 40(3), 218-222. doi:10.1139/apnm-2014-0338
• Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012). FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism, 61(12), 1725-1738. doi:10.1016/j.metabol.2012.09.002
• Irving, B. A., Still, C. D., & Argyropoulos, G. (2014). Does IRISIN Have a BRITE Future as a Therapeutic Agent in Humans? Curr Obes Rep, 3, 235-241. doi:10.1007/s13679-014-0091-1
• Kristin I. Stanford, R. J. W. M., Kristy L. Townsend, Ding An, Eva B. Nygaard, Kristen M. Hitchcox, Kathleen R. Markan, Kazuhiro Nakano, Michael F. Hirshman, Yu-Hua Tseng, Laurie J. Goodyear. (2013). Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. The Journal of Clinical Investigation, 123, 215-223. doi:10.1172/JCI62308
• Kumar, K. G., Trevaskis, J. L., Lam, D. D., Sutton, G. M., Koza, R. A., Chouljenko, V. N., . . . Butler, A. A. (2008). Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab, 8(6), 468-481. doi:10.1016/j.cmet.2008.10.011
• Lovren, F., Pan, Y., Quan, A., Singh, K. K., Shukla, P. C., Gupta, M., . . . Verma, S. (2010). Adropin is a novel regulator of endothelial function. Circulation, 122(11 Suppl), S185-192. doi:10.1161/CIRCULATIONAHA.109.931782
• Mohammad Rahimi, G. R., Bijeh, N., & Rashidlamir, A. (2020). Effects of exercise training on serum preptin, undercarboxylated osteocalcin and high molecular weight adiponectin in adults with metabolic syndrome. Exp Physiol, 105(3), 449-459. doi:10.1113/EP088036
• Norheim, F., Langleite, T. M., Hjorth, M., Holen, T., Kielland, A., Stadheim, H. K., . . . Drevon, C. A. (2014). The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in humans. FEBS J, 281(3), 739-749. doi:10.1111/febs.12619
• Pardo, M., Crujeiras, A. B., Amil, M., Aguera, Z., Jimenez-Murcia, S., Banos, R., . . . Casanueva, F. F. (2014). Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol, 2014, 857270. doi:10.1155/2014/857270
• Pekkala, S., Wiklund, P. K., Hulmi, J. J., Ahtiainen, J. P., Horttanainen, M., Pollanen, E., . . . Cheng, S. (2013). Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol, 591(21), 5393-5400. doi:10.1113/jphysiol.2013.263707
• Perakakis, N., Triantafyllou, G. A., Fernandez-Real, J. M., Huh, J. Y., Park, K. H., Seufert, J., & Mantzoros, C. S. (2017). Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol, 13(6), 324-337. doi:10.1038/nrendo.2016.221
• Polyzos, S. A., Anastasilakis, A. D., Efstathiadou, Z. A., Makras, P., Perakakis, N., Kountouras, J., & Mantzoros, C. S. (2018). Irisin in metabolic diseases. Endocrine, 59(2), 260-274. doi:10.1007/s12020-017-1476-1
• Sayin, O., Tokgoz, Y., & Arslan, N. (2014). Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. J Pediatr Endocrinol Metab, 27(5-6), 479-484. doi:10.1515/jpem-2013-0296
• Spiegelman, B. M., & Korsmeyer, S. J. (2012). Irisin and the therapeutic benefits of exercise. BMC Proceedings, 6(Suppl 3), O23. doi:10.1186/1753-6561-6-s3-o23
• Stengel, A., Hofmann, T., Goebel-Stengel, M., Elbelt, U., Kobelt, P., & Klapp, B. F. (2013). Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index. Peptides, 39, 125-130. doi:10.1016/j.peptides.2012.11.014
• Timmons, J. A., Baar, K., Davidsen, P. K., & Atherton, P. J. (2012). Is irisin a human exercise gene? Nature, 488(7413), E9-10; discussion E10-11. doi:10.1038/nature11364
• Yang, G., Li, L., Chen, W., Liu, H., Boden, G., & Li, K. (2009). Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Ann Med, 41(1), 52-56. doi:10.1080/07853890802244142
• Yu, H. Y., Zhao, P., Wu, M. C., Liu, J., & Yin, W. (2014). Serum adropin levels are decreased in patients with acute myocardial infarction. Regul Pept, 190-191, 46-49. doi:10.1016/j.regpep.2014.04.001
• Zhao, L. P., Xu, W. T., Wang, L., You, T., Chan, S. P., Zhao, X., & Yang, X. J. (2015). Serum adropin level in patients with stable coronary artery disease. Heart Lung Circ, 24(10), 975-979. doi:10.1016/j.hlc.2015.03.008